>
pdufa.bio

AP01

Updated ยทnext FDA decision on the calendar

AP01 is a Avalyn Pharma Inc. program. Its next catalyst is a Readout in Jun 2027. Every date links its source.

AVLN catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Avalyn Pharma Inc. (AVLN). We track 1 catalyst event for this program: 1 upcoming and 0 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Jun 2027AVLN

Questions

When is AP01's next FDA decision or readout?

The next tracked catalyst for AP01 is a Readout in Jun 2027.

What happened at AP01's most recent FDA decision?

No FDA decision for AP01 is in our archive yet.

Who makes AP01?

Avalyn Pharma Inc. (AVLN).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.